Chemours (CC) Operating Expenses (2014 - 2026)

Chemours has reported Operating Expenses for 13 years, with the latest figure at $499.0 million in Q2 2026.

• On a quarterly basis, Operating Expenses rose 6.17% year-over-year to $499.0 million in Q2 2026; TTM through Jun 2026 was $998.0 million, a 11.21% decrease from a year earlier, with the FY2025 full-year figure at $966.0 million, up 17.38% from the prior year.
• Operating Expenses was $499.0 million for Q2 2026 at Chemours, up from $186.0 million in the prior quarter.
• The five-year high for Operating Expenses was $806.0 million in Q2 2023, with the low at $152.0 million in Q3 2025.
• Average Operating Expenses over 5 years is $270.3 million, with a median of $195.0 million recorded in 2024.
• The sharpest annual moves came in 2023 and 2024: Operating Expenses soared 187.86% in 2023, then sank 77.3% in 2024.
• Over 5 years, Operating Expenses stood at $211.0 million in 2022, then rose by 21.8% to $257.0 million in 2023, then retreated by 20.62% to $204.0 million in 2024, then fell by 21.08% to $161.0 million in 2025, then surged by 209.94% to $499.0 million in 2026.
• The last three Operating Expenses figures came in at $499.0 million (Q2 2026), $186.0 million (Q1 2026), and $161.0 million (Q4 2025), per Business Quant data.